ArticlePloS one2022

Pharmaceutical care program for patients with chronic kidney disease in the community pharmacy: Detection of nephrotoxic drugs and dose adjustment. Viability study.

Gema Escribá-Martí et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.